Heart stent trial aims to cut bleeding risk with shorter blood thinner course
NCT ID NCT05650411
First seen Jan 10, 2026 · Last updated May 01, 2026 · Updated 18 times
Summary
This study compares a new ultrathin drug-coated stent plus a shorter course of dual blood thinners (1-3 months) followed by a single blood thinner, versus the standard 12-month dual blood thinner regimen, in 828 people with left main coronary artery disease. The goal is to see if the new approach reduces bleeding risk without increasing heart attacks or the need for repeat procedures. Participants must have already received the new stent successfully.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEFT MAIN CORONARY ARTERY STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zurich University Hospital
Zurich, Canton of Zurich, Switzerland
Contact
Contact
Conditions
Explore the condition pages connected to this study.